These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7087658)

  • 21. Developmental changes in [3H]lysergic acid diethylamide ([3H]LSD) binding to serotonin receptors in the human brainstem.
    Zec N; Filiano JJ; Panigrahy A; White WF; Kinney HC
    J Neuropathol Exp Neurol; 1996 Jan; 55(1):114-26. PubMed ID: 8558166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [125I]LSD labels 5-HT1C recognition sites in pig choroid plexus membranes. Comparison with [3H]mesulergine and [3H]5-HT binding.
    Hoyer D; Srivatsa S; Pazos A; Engel G; Palacios JM
    Neurosci Lett; 1986 Sep; 69(3):269-74. PubMed ID: 3763057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereospecific binding of D-lysergic acid diethylamide (LSD) to brain membranes: relationship to serotonin receptors.
    Bennett JP; snyder SH
    Brain Res; 1975 Sep; 94(3):523-44. PubMed ID: 239784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysergic acid diethylamide: evidence for stimulation of cerebral dopamine receptors.
    Prada MD; Saner A; Burkark WP; Bartholini G; Pletscher A
    Brain Res; 1975 Aug; 94(1):67-73. PubMed ID: 1148867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine receptors in the central nervous system.
    Seeman P; Tedesco JL; Lee T; Chau-Wong M; Muller P; Bowles J; Whitaker PM; McManus C; Tittler M; Weinreich P; Friend WC; Brown GM
    Fed Proc; 1978 Feb; 37(2):131-6. PubMed ID: 414936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel serotonin receptors in Fasciola. Characterization by studies on adenylate cyclase activation and [3H]LSD binding.
    McNall SJ; Mansour TE
    Biochem Pharmacol; 1984 Sep; 33(17):2789-97. PubMed ID: 6466386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age dependent changes in serotonin and dopamine receptors in Aplysia californica.
    Southall MD; Flinn JM; Holt RW; Chandhoke V
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1997 Oct; 118(2):137-41. PubMed ID: 9440239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo binding of 125I-LSD to serotonin 5-HT2 receptors in mouse brain.
    Hartig PR; Scheffel U; Frost JJ; Wagner HN
    Life Sci; 1985 Aug; 37(7):657-64. PubMed ID: 3160905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological characterization of solubilized 5-HT1 serotonin binding sites from bovine brain.
    Allgren RL; Kyncl MM; Ciaranello RD
    Brain Res; 1985 Nov; 348(1):77-85. PubMed ID: 4063829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [High affinity binding of 5-hydroxytryptamine to some membrane preparations from cattle brain. Relationship to lysergic acid diethylamide (LSD)].
    Fillion G; Fillion MP; Rousselle JC; Beaudoin D; Goiny M; Jacob J
    C R Acad Hebd Seances Acad Sci D; 1977 Mar; 284(11):979-81. PubMed ID: 405135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotoninergic receptors in brain tissue: properties and identification of various 3H-ligand binding sites in vitro.
    Leysen JE
    J Physiol (Paris); 1981; 77(2-3):351-62. PubMed ID: 7288650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serotonin and D-lysergic acid diethylamide receptors in the mammalian brain].
    Vlasova TI; Kirzon MV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1981; (5):5-16. PubMed ID: 6264979
    [No Abstract]   [Full Text] [Related]  

  • 34. Serotonin and dopamine receptors in the rat pituitary gland: autoradiographic identification, characterization, and localization.
    De Souza EB
    Endocrinology; 1986 Oct; 119(4):1534-42. PubMed ID: 2944737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
    Sanders-Bush E; Burris KD; Knoth K
    J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonism of 5-hydroxytryptamine2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide.
    Pierce PA; Peroutka SJ
    J Pharmacol Exp Ther; 1988 Dec; 247(3):918-25. PubMed ID: 3204523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased spiroperidol and LSD binding in rat brain after continuous amphetamine.
    Nielsen EB; Nielsen M; Ellison G; Braestrup C
    Eur J Pharmacol; 1980 Aug; 66(2-3):149-54. PubMed ID: 7439269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Displacement of specific serotonin and lysergic acid diethylamide binding by Ergalgin, a new antiserotonin drug.
    Oelszner W
    Acta Biol Med Ger; 1980; 39(8-9):897-901. PubMed ID: 7282219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and radioautography of [3H]LSD binding by rat brain slices in vitro: the effect of 5-hydroxytryptamine.
    Meibach RC; Maayani S; Green JP
    Eur J Pharmacol; 1980 Oct; 67(4):371-82. PubMed ID: 7449822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Agonist-directed signaling of serotonin 5-HT2C receptors: differences between serotonin and lysergic acid diethylamide (LSD).
    Backstrom JR; Chang MS; Chu H; Niswender CM; Sanders-Bush E
    Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):77S-81S. PubMed ID: 10432492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.